PHA-665752’s Antigrowth and Proapoptotic Effects on HSC-3 Human Oral Cancer Cells
Open Access
- 1 March 2024
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (5) , 2871
Abstract
C-Met is a tyrosine-kinase receptor, and its aberrant activation plays critical roles in tumorigenesis, invasion, and metastatic spread in many human tumors. PHA-665752 (PHA) is an inhibitor of c-Met and has antitumor effects on many hematological malignancies and solid cancers. However, the activation and expression of c-Met and its role and the antitumor effect of PHA on human oral squamous cell carcinoma (OSCC) cells remain unclear. Here, we investigated the activation and expression of c-Met and the effects of PHA on the growth of a highly tumorigenic HSC-3 human OSCC cell line with high c-Met phosphorylation and expression. Of note, c-Met was highly expressed and phosphorylated on Y1234/1235 in HSC-3 cells, and PHA treatment significantly suppressed the growth and induced apoptosis of these cells. Moreover, PHA that inhibited the phosphorylation (activation) of c-Met further caused the reduced phosphorylation and expression levels of Src, protein kinase B (PKB), mammalian target of rapamycin (mTtor), and myeloid cell leukemia-1 (Mcl-1) in HSC-3 cells. In addition, the antiangiogenic property of PHA in HSC-3 cells was shown, as evidenced by the drug’s suppressive effect on the expression of hypoxia-inducible factor-1α (HIF-1α), a critical tumor angiogenic transcription factor. Importantly, genetic ablation of c-Met caused the reduced growth of HSC-3 cells and decreased Src phosphorylation and HIF-1α expression. Together, these results demonstrate that c-Met is highly activated in HSC-3 human oral cancer cells, and PHA exhibits strong antigrowth, proapoptotic, and antiangiogenic effects on these cells, which are mediated through regulation of the phosphorylation and expression of multiple targets, including c-Met, Src, PKB, mTOR, Mcl-1, and HIF-1α.Keywords
Funding Information
- National Research Foundation of Korea (2022-00166883)
This publication has 55 references indexed in Scilit:
- A Combination of Two Receptor Tyrosine Kinase Inhibitors, Canertinib and PHA665752 Compromises Ovarian Cancer Cell Growth in 3D Cell ModelsOncology and Therapy, 2016
- Apigenin Inhibits Cancer Stem Cell‐Like Phenotypes in Human Glioblastoma Cells via Suppression of c‐Met SignalingPhytotherapy Research, 2016
- Study of critical role of c-Met and its inhibitor SU11274 in colorectal carcinomaMedical Oncology, 2013
- Hypoxia-inducible factor-1α mediates oral squamous cell carcinoma invasion via upregulation of α5 integrin and fibronectinBiochemical and Biophysical Research Communications, 2010
- The prognostic role of phospho-Src family kinase analysis in tongue cancerJournal of Cancer Research and Clinical Oncology, 2009
- Function of Akt/PKB signaling to cell motility, invasion and the tumor stroma in cancerCellular Signalling, 2009
- Insights into the PI3-K-PKB-mTOR signalling pathway from small moleculesJournal of Chemical Biology, 2008
- Characterization of 3 Oral Squamous Cell Carcinoma Cell Lines With Different Invasion and/or Metastatic PotentialsJournal of Oral and Maxillofacial Surgery, 2007
- AKT/PKB Signaling: Navigating DownstreamCell, 2007
- Molecular markers of head and neck squamous cell carcinoma: Promising signs in need of prospective evaluationHead & Neck, 2005